BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China
· Delayed Price · Currency is CNY 40.92
+0.65 (1.61%)
Mar 6, 2026, 4:00 PM EST
SHA:688166 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 17,015 | 20,740 | 12,748 | 14,786 | 9,535 | 15,051 | Upgrade
|
| Market Cap Growth | 32.34% | 62.70% | -13.79% | 55.07% | -36.65% | -19.85% | Upgrade
|
| Enterprise Value | 18,834 | 22,558 | 14,391 | 15,983 | 10,606 | 15,560 | Upgrade
|
| Last Close Price | 40.25 | 49.06 | 30.15 | 34.85 | 22.36 | 36.17 | Upgrade
|
| PE Ratio | 303.54 | 369.98 | 67.39 | 73.03 | 39.79 | 61.70 | Upgrade
|
| Forward PE | - | 28.00 | 28.00 | 28.00 | 28.00 | 43.06 | Upgrade
|
| PS Ratio | 13.91 | 16.95 | 9.94 | 12.54 | 9.37 | 14.30 | Upgrade
|
| PB Ratio | 6.72 | 8.19 | 5.23 | 6.12 | 4.25 | 8.64 | Upgrade
|
| P/TBV Ratio | 7.21 | 8.79 | 5.54 | 6.52 | 4.54 | 9.47 | Upgrade
|
| P/OCF Ratio | - | - | 51.91 | 75.92 | 30.63 | 85.48 | Upgrade
|
| EV/Sales Ratio | 15.39 | 18.43 | 11.22 | 13.55 | 10.43 | 14.79 | Upgrade
|
| EV/EBITDA Ratio | 168.15 | 201.40 | 48.52 | 58.11 | 39.13 | 54.92 | Upgrade
|
| EV/EBIT Ratio | - | 1393.20 | 71.68 | 76.75 | 45.84 | 62.45 | Upgrade
|
| Debt / Equity Ratio | 0.93 | 0.93 | 0.92 | 0.91 | 0.90 | 0.52 | Upgrade
|
| Debt / EBITDA Ratio | 20.90 | 20.90 | 7.20 | 7.71 | 7.17 | 3.10 | Upgrade
|
| Net Debt / Equity Ratio | 0.69 | 0.69 | 0.60 | 0.48 | 0.35 | 0.32 | Upgrade
|
| Net Debt / EBITDA Ratio | 15.49 | 15.49 | 4.96 | 4.21 | 2.92 | 1.99 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -126.33 | -5.54 | -1.90 | -0.77 | Upgrade
|
| Asset Turnover | - | - | 0.25 | 0.24 | 0.27 | 0.44 | Upgrade
|
| Inventory Turnover | - | - | 1.58 | 1.74 | 1.63 | 2.33 | Upgrade
|
| Quick Ratio | - | - | 1.06 | 1.49 | 1.92 | 1.23 | Upgrade
|
| Current Ratio | - | - | 1.56 | 2.00 | 2.39 | 1.70 | Upgrade
|
| Return on Equity (ROE) | 2.26% | 2.26% | 5.82% | 7.44% | 10.62% | 14.97% | Upgrade
|
| Return on Assets (ROA) | - | - | 2.46% | 2.69% | 3.79% | 6.49% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.38% | 0.40% | 4.82% | 5.79% | 7.57% | 13.37% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 4.90% | 5.10% | 6.00% | 10.40% | Upgrade
|
| Earnings Yield | 0.33% | 0.27% | 1.48% | 1.37% | 2.51% | 1.62% | Upgrade
|
| FCF Yield | - | - | -0.09% | -1.41% | -4.36% | -4.87% | Upgrade
|
| Dividend Yield | 0.23% | - | 0.32% | 0.27% | 0.51% | 0.33% | Upgrade
|
| Payout Ratio | - | - | 71.75% | 56.80% | 41.77% | 22.26% | Upgrade
|
| Buyback Yield / Dilution | -2.58% | -2.58% | 0.34% | -2.10% | -1.61% | 1.87% | Upgrade
|
| Total Shareholder Return | -2.34% | -2.58% | 0.66% | -1.82% | -1.10% | 2.21% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.